MediWound (MDWD) details director Stephen Wills’ initial share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
MediWound Ltd. filed an initial ownership report for director Stephen T. Wills, detailing his existing holdings in ordinary shares and stock options. The filing lists multiple stock option awards on ordinary shares with exercise prices ranging from 11.8850 to 37.5200 and expiration dates between 2029 and 2036. It also notes ordinary shares underlying RSUs and an option grant made on March 4, 2026 that vest 100% on the one-year anniversary of the grant date, showing his current equity-based alignment with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
WILLS STEPHEN T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 2,857 shares (Direct);
Ordinary shares — 9,679 shares (Direct)
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
FAQ
What does MediWound (MDWD) disclose in Stephen T. Wills’ Form 3 filing?
The Form 3 lists Stephen T. Wills’ existing holdings in MediWound equity. It details ordinary shares and several stock option grants on ordinary shares, including exercise prices, expiration dates, and specific vesting terms for awards granted on March 4, 2026.
What stock options are reported for Stephen T. Wills in MediWound (MDWD)?
The filing lists several stock option awards to buy MediWound ordinary shares. Each option series shows an exercise price, underlying ordinary shares, and expiration dates ranging from 2029 to 2036, outlining his long-dated incentive exposure to the company’s equity.
What are the vesting terms of the March 4, 2026 MediWound (MDWD) grants to Stephen T. Wills?
Footnotes state that RSUs and options granted on March 4, 2026 vest 100% on the one-year anniversary of the grant date. This means those awards become fully vested after one year, subject to the stated terms, strengthening his near-term equity incentives.
How does the Form 3 characterize Stephen T. Wills’ ownership type in MediWound (MDWD)?
All listed positions are coded as direct ownership. Each row uses a direct ownership code and does not reference any trusts or entities in the nature-of-ownership field, indicating the holdings are reported as directly owned by Stephen T. Wills.